The Effects of Omega-3 Fatty Acids on Metabolic Syndrome
Status unconfirmed · Early Phase 1
Conditions studied: Metabolic Syndrome X
In brief
The purpose of this study is to determine the effects of omega-3 fatty acids in the form of fish oil supplementation (approximately 2 grams per day) on the carotid intima-media (CIMT)progression (primary objective) and 2)(Secondary objective) lipid markers such as LDL, apo-B, and LDL buoyancy, on inflammatory burden as measured by CRP, on oxidative stress as measured by urinary isoprostanes, urine microalbumin/creatinine, and serum adiponectin a fat derived hormone in subjects with metabolic syndrome.
Key facts
- Study ID
- NCT00350194
- Run by
- University of Washington
- People needed
- 100
- Starts
- 2006-10-01
- Expected to finish
- 2012-06-01
- Last updated by the study team
- 2012-03-02
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Adults with Metabolic Syndrome (meets 3 of the following 5)
- Abdominal obesity, waist circumference in men greater than 40 in. \& in women greater than 35 in.
- Serum triglycerides greater than or = 150 mg/dL (1.7 mmol/L)
- Serum HDL cholesterol less than or = 40 mg/dL in men and less than 50 mg/dL in women
- Blood pressure greater than or = 130/85 mmHg or drug treatment for elevated blood pressure
- Fasting plasma glucose greater than 100 mg/dL
You may not qualify if…
- Diabetes
- Known or documented CHD (including ECG consistent with prior MI), CVA (including TIA), PVD (including symptoms of claudication)
- Angina or other chest pain that may indicate CHD
- Clinically significant neoplastic, cardiovascular, hepatic, renal, metabolic, endocrine (untreated or unstable), or psychiatric (untreated or unstable)
- Known abnormal LFTS greater than 2X ULN
- Smoker, illicit drug use, or excessive alcohol use
- Medications: Lipid lowering therapy, daily NSAID or greater than 325 mg ASA (PRN use ok), clopidogrel (or equivalent), Coumadin, Omega-3 fatty acid supplement, other investigational drugs within 30 days of study entry, high omega-3 fatty acid content in diet within past three months
- Pregnancy or planning pregnancy during the study period
- Sensitivity or allergy to fish
Where it is running
- Northwest Lipid Research Clinic (University of Washington Affiliated) — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.